Literature DB >> 21557230

Functional outcomes and suitability of the temporalis myofascial flap for palatal and maxillary reconstruction after oncologic resection.

J Dale Browne1, Susan Butler, Catherine Rees.   

Abstract

OBJECTIVES/HYPOTHESIS: The temporalis myofascial flap (TMF) is a method of palatal reconstruction that offers a single-stage, reliable, and functional technique to repair oncologic defects involving the oral cavity following tumor removal. It is hypothesized that both speech and swallowing function are preserved following TMF. STUDY
DESIGN: In a retrospective and prospective case series, this study evaluated the surgical outcomes of 72 patients undergoing surgical resection and reconstruction of the hard and soft palate using a TMF. Of this series, 25 patients underwent nasalence and swallowing quality-of-life testing to determine speech and swallowing function following this procedure.
METHODS: Reliability, safety, and effectiveness data endpoints on TMF reconstruction were collected and analyzed. Instrumental measures of nasalence (KayPentax Nasometer, Lincoln Park, NJ) and swallowing quality of life measures (MD Anderson Dysphagia Inventory [MDADI] were acquired.
RESULTS: All TMF's were successfully transferred with complete healing of the oncologic defect. The group mean nasalence for connected speech tasks were within normal limits for connected speech--high- and low-pressure tasks (M = 21% and M = 17%). The group mean nasalence scores for sustained vowels were mildly affected (M = 26%). The group mean MDADI score was 79 (SD = 16), indicating good to mildly affected swallowing quality of life. Neither nasalence nor MDADI scores appeared to vary as a function of defect region.
CONCLUSIONS: The TMF is an oncologically safe and effective method of palate reconstruction that affords excellent quality of life to appropriately selected patients without reliance on other reconstructive techniques.
Copyright © 2011 The American Laryngological, Rhinological, and Otological Society, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21557230     DOI: 10.1002/lary.21747

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  6 in total

1.  Swallowing-related outcomes associated with late lower cranial neuropathy in long-term oropharyngeal cancer survivors: cross-sectional survey analysis.

Authors:  Puja Aggarwal; Jhankruti S Zaveri; Ryan P Goepfert; Qiuling Shi; Xianglin L Du; Michael Swartz; Stephen Y Lai; C David Fuller; Jan S Lewin; Linda B Piller; Katherine A Hutcheson
Journal:  Head Neck       Date:  2019-08-23       Impact factor: 3.147

2.  Unforeseen Outcomes Post Treatment for Radiation Induced Trismus: A Case Report.

Authors:  Akash Sivam; Ankit Garg; Paul Sillifant
Journal:  Medicines (Basel)       Date:  2022-04-19

Review 3.  Polymorphous adenocarcinoma of the salivary glands: reappraisal and update.

Authors:  Vincent Vander Poorten; Asterios Triantafyllou; Alena Skálová; Göran Stenman; Justin A Bishop; Esther Hauben; Jennifer L Hunt; Henrik Hellquist; Simon Feys; Remco De Bree; Antti A Mäkitie; Miquel Quer; Primož Strojan; Orlando Guntinas-Lichius; Alessandra Rinaldo; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-05-14       Impact factor: 2.503

4.  Reconstruction of palatomaxillary defects following cancer ablation with temporalis muscle flap in medically compromised patients: a 15-year single institutional experience.

Authors:  Yanling Wang; Jie Cheng; Chunping Yuan; Zhongwu Li; Dongmiao Wang; Xu Ding; Jinhai Ye; Heming Wu; Linzhong Wan; Zhenjiang Tao; Hongbing Jiang; Yunong Wu
Journal:  Clin Oral Investig       Date:  2013-11-19       Impact factor: 3.573

5.  The Temporalis Muscle Flap for Palate Reconstruction: Case Series and Review of the Literature.

Authors:  Tara Brennan; Tristan M Tham; Peter Costantino
Journal:  Int Arch Otorhinolaryngol       Date:  2017-02-17

6.  Temporalis Muscle Flap for the Immediate Reconstruction of Oral Defects after Oncologic Resection.

Authors:  Hong Loi Nguyen; Van Minh Nguyen; Xuan Phu Tran
Journal:  Case Rep Oncol       Date:  2021-03-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.